Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral 2,3 disubstituted indoleamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461589A details a novel one-step asymmetric Friedel-Crafts reaction yielding high-purity chiral indoleamines with significant cost reduction potential.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.